ACTREC Project Research Scientist-I (Non-Medical) 2026: Why Two Kinds of Experience Matter

Advertisement ACTREC/ADVT-218/2026 | Issued 21 October 2026 | Walk-in: Friday, 6 November | Reporting: 10:00–10:30 AM

A Life Sciences postgraduate degree is the starting point, not the whole eligibility test. ACTREC's one-page notice combines at least six months of recruiting patients for study participation with in-vitro proteomics work. It also says candidates without the prescribed experience cannot participate in the interview. That makes the most useful question for an applicant unusually specific: Can you independently document both the patient-facing recruitment work and the proteomics work you have actually done?

🎓 The eligibility test is a combination, not a menu

The notice's two essential experience clauses should not be collapsed into the vague label research experience. A candidate can have several years in a molecular laboratory and still lack the specified patient-study recruitment work. Conversely, general patient interaction or coordinating visits does not automatically demonstrate in-vitro proteomics.

The word “Furthermore” connects the in-vitro work to the six-month study-recruitment requirement. It does not publish an alternative choice between the two. The same sentence says lack of experience prevents attending the interview. The notice does not state that the six months must be after the postgraduate degree, nor does it list acceptable Life Sciences specialisations individually; avoid treating either interpretation as an official rule.

How to document the experience without exaggeration

An experience certificate that merely says “research assistant” may not show what ACTREC actually asks for. Prepare truthful supporting evidence that describes your real activities. This is an applicant preparation strategy, not an ACTREC-prescribed certificate format.

The advertisement does not demand a named assay, a specific mass spectrometer, a minimum number of enrolled patients, a particular software suite, a research publication, or a specified clinical-trial phase. Avoid asserting those as compulsory just because they are familiar concepts in translational research.

🧬 What this specific cancer project is trying to study

The project's stated purpose is the identification and validation of a potential protein biomarker panel for head and neck squamous cell carcinoma (HNSCC). The distinction between identification and validation matters scientifically: finding candidate signals is not the same as showing that a reproducible signal retains meaning under further testing. A panel concerns more than treating one protein measurement as a complete clinical answer. These are interpretations of the project title, not a disclosed study protocol.

ACTREC's own Mass Spectrometry facility describes both discovery-scale protein profiling and targeted proteomics capability, and its published research profile lists prior proteomics work involving HNSCC. This helps a candidate understand why a team might value someone who bridges study-participant workflows and protein-focused experimental work. It does not establish that the new appointment is attached to that particular facility or laboratory. The notice names no principal investigator, sample type, platform, patient cohort size, recruitment target, bioinformatics package, assay panel size, sensitivity/specificity threshold, or regulatory endpoint.

That boundary matters: a well-researched preparation note should explain the relevance of proteomics, but it must not convert ACTREC's institutional equipment inventory into a new eligibility condition. The laboratory's public description mentions high-resolution and targeted mass-spectrometry applications as institutional context, not the mandatory workplan of this advertised post.

Interview discussion areas — preparation, not an announced syllabus

There is no official question distribution or marks scheme. Applicants can nevertheless organise their own authentic work history around three questions: how the patient-study recruitment was conducted in their actual workplace; which proteomics steps they personally performed; and how they understood the link between translational biomarker research and credible study records. If discussing participant consent, ethics, privacy, sample traceability, experimental controls or batch effects, describe only what your own work supports. ACTREC has not published these as fixed compulsory interview topics.

💰 ₹72,800 salary: what the figure includes

The advertisement provides its calculation, avoiding the usual uncertainty around “salary plus HRA”:

ACTREC Scientist-I salary split: base and HRA

Base pay, HRA and the consolidated total compared

The pie visualises 76.92% base and 23.08% HRA within the published total. The bar chart compares the two components against that same ₹72,800 figure. The total bar is not a third allowance. In particular, the appointment does not offer ₹72,800 plus another 30% HRA. No official take-home amount, deduction schedule, increment policy, travel reimbursement or supplementary allowance is specified. These numbers are consolidated pay components, not Pay Matrix Levels.

⏳ Six months confirmed; extension is a decision, not a promise

The original wording is “Six months and extendable” and adds that candidates' work progress will be monitored before extension may be granted. So the first six months are the advertised initial tenure. A twelve-month guaranteed contract, a two-year upper limit, annual increments, a permanent career track or an automatic renewal cannot be inferred. An applicant relocating to Navi Mumbai should evaluate the six-month commitment rather than pricing a speculative second term into a financial decision.

Research scope matters to tenure. The duties sentence is not restricted to the single biomarker project: it also says the candidate must perform research on different ongoing projects. That is an official expectation of some flexibility, though exact assignments and supervisors have not been published.

📅 Job lifecycle — only the announced date enters the schedule

The 30-minute reporting window is not a 30-minute written paper and does not determine the duration of the interview. Plan to reach the actual venue for reporting rather than assuming an afternoon slot. The advertisement invites eligible people to attend physically and does not require a separate web registration, fee payment or uploaded application in advance. It does not promise that arriving after 10:30 AM will be accepted.

Walk-in interview file — original notice versus practical organisation

ACTREC explicitly asks candidates to bring: a recent CV, originals and photocopies of all relevant educational and work-experience certificates, a recent passport-size photograph and photo ID (Aadhaar preferred, not described as the only valid ID). Organising the originals and copies in the same order as the CV is a practical suggestion, not a separate official eligibility rule.

What it does not demand in this notice: a specific application form, separate prior email application, NET/GATE scorecard, particular instrument certification, printed study protocol, formal publication list, a stated number of certificate sets or a named exam syllabus. Some of these could be personally useful supporting papers; do not label them mandatory based on assumptions.

🔍 Four applicant profiles — the actual eligibility risk

There is no published numerical vacancy count in this notice. Therefore a “one vacancy, unreserved” interpretation, a reservation pie chart or a category-wise selection probability would be invented. The official page lists the role and walk-in date, but does not supply the missing roster. Maximum age is 35 years; the notice gives no reference date or individual category relaxation schedule, so these should remain unspecified in the structured Age Rules too.

Official references

• Signed ACTREC notice — ACTREC/ADVT-218/2026 (21 October 2026)
• ACTREC current walk-in vacancies and updates
• ACTREC Mass Spectrometry facility — research background, not appointment criteria
• ACTREC HNSCC proteomics research profile — historical institutional context only